Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Sacheerome Ltd
Quarter-by-quarter operating performance
Financials of Sacheerome Ltd
Annual income statement trend
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales + | 64 | 70 | 85 | 108 | 152 |
| Expenses + | 55 | 61 | 70 | 85 | 116 |
| Operating Profit | 9 | 10 | 15 | 23 | 37 |
| OPM % | 13% | 14% | 18% | 21% | 24% |
| Other Income + | 0 | 0 | 1 | 1 | 4 |
| Interest | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 |
| Profit before tax | 6 | 8 | 15 | 21 | 38 |
| Tax % | 27% | 28% | 27% | 25% | 25% |
| Net Profit + | 5 | 6 | 11 | 16 | 28 |
| EPS in Rs | 11.14 | 14.67 | 6.50 | 9.78 | 12.71 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
Financials of Sacheerome Ltd
Capital structure and asset base
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 4 | 4 | 16 | 16 | 22 |
| Reserves | 25 | 31 | 30 | 46 | 126 |
| Borrowings + | 8 | 0 | 1 | 3 | 0 |
| Other Liabilities + | 11 | 14 | 16 | 19 | 24 |
| Total Liabilities | 49 | 49 | 64 | 85 | 172 |
| Fixed Assets + | 9 | 21 | 22 | 23 | 23 |
| CWIP | 0 | 2 | 8 | 28 | 57 |
| Investments | 0 | 0 | 0 | 0 | 1 |
| Other Assets + | 40 | 27 | 33 | 34 | 90 |
| Total Assets | 49 | 49 | 64 | 85 | 172 |
Financials of Sacheerome Ltd
Operating, investing and financing cash movement
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from Operating Activity + | 9 | 11 | 10 | 22 | |
| Cash from Investing Activity + | -4 | -2 | -10 | -23 | |
| Cash from Financing Activity + | -6 | -9 | 1 | 2 | |
| Net Cash Flow | -1 | 0 | 1 | 1 | |
| Free Cash Flow | 6 | 9 | 0 | -2 | |
| CFO/OP | 141% | 128% | 91% | 124% |
Financials of Sacheerome Ltd
Working capital efficiency and return ratios
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor Days | 67 | 63 | 68 | 52 | 47 |
| Inventory Days | 113 | 100 | 85 | 63 | 47 |
| Days Payable | 71 | 73 | 73 | 80 | 61 |
| Cash Conversion Cycle | 109 | 89 | 80 | 35 | 34 |
| Working Capital Days | 37 | 63 | 58 | 24 | 31 |
| ROCE % | 24% | 36% | 39% | 36% |
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…
Long-term demand-supply balance looks stable with 6-7% market growth, supporting sustained revenues despite new capacity additions. Key concall takeaways from…